Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;39(5):671-81.
doi: 10.1007/s10802-011-9511-9.

Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence

Affiliations

Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence

Christian S Hendershot et al. J Abnorm Child Psychol. 2011 Jul.

Abstract

Evidence for shared heritable influences across domains of substance use suggests that some genetic variants influence broad risk for externalizing behaviors. Theories of externalizing psychopathology also suggest that genetic liability for substance use manifests as temperamental risk factors, particularly those related to behavioral disinhibition, during adolescence. The cholinergic muscarinic receptor 2 gene (CHRM2) is a promising candidate for studying genetic influences on broad-based risk for externalizing traits. This study examined a candidate CHRM2 polymorphism (rs1455858) in relation to substance use and personality measures of disinhibition in a sample of high-risk adolescents (n = 124). Bivariate analyses and structural equation modeling (SEM) evaluated associations of rs1455858 with measures of drug involvement (alcohol, tobacco and marijuana) and disinhibition (indexed by impulsivity and sensation seeking scores). Bivariate analyses showed significant associations of CHRM2 with several behavioral phenotypes. In SEM analyses CHRM2 related significantly to latent measures of substance use and disinhibition; additionally, disinhibition mediated the association of CHRM2 with substance use. These results suggest that CHRM2 variants are potentially relevant for adolescent substance use and that temperamental risk factors could contribute to these associations.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Location of rs1455858 (chromosome 7) and linkage disequilibrium (D’) structure (HapMap3, release 2).
Figure 2
Figure 2
Structural equation model evaluating a temperamental index of disinhibition (assessed at Time 1) as mediating the association of CHRM2 with risk for substance use (assessed at Time 2). IMP = impulsivity; SS = sensation seeking; ALC-F = alcohol use frequency; ALC-Q = typical drinking quantity; MJ PROB = number of marijuana-related problems endorsed; MJ FREQ = frequency of marijuana use; CIG USE = smoking status (0 = no, 1 = yes); CIG-Q = typical number of cigarettes per day. Race/ethnicity and gender are controlled for in this analysis. Path coefficients are standardized. * p < .05 ** p < .01 *** p < .001

Similar articles

Cited by

References

    1. Agrawal A, Lynskey MT. The genetic epidemiology of cannabis use, abuse and dependence. Addictive Behaviors. 2006;101:801–812. - PubMed
    1. Agrawal A, Lynskey MT. Are there genetic influences on addiction? Evidence from family, adoption and twin studies. Addiction. 2008;103:1069–1081. - PubMed
    1. Agrawal A, Neale MC, Jacobson KC, Prescott CA, Kendler KS. Illicit drug use and abuse/dependence: Modeling of two-stage variables using the CCC approach. Addictive Behaviors. 2005;30:1043–1048. - PubMed
    1. Aron AR, Poldrack RA. Cortical and subcortical contributions to Stop signal response inhibition: Role of the subthalamic nucleus. Journal of Neuroscience. 2006;26:2424–2433. - PMC - PubMed
    1. Banich MT, Crowley TJ, Thompson LL, Jacobson BL, Liu X, Raymond KM, Claus ED. Brain activation during the Stroop task in adolescents with severe substance and conduct problems: A pilot study. Drug and Alcohol Dependence. 2007;90:175–182. - PMC - PubMed

Publication types

Substances